0000899243-19-015014.txt : 20190529
0000899243-19-015014.hdr.sgml : 20190529
20190529162215
ACCESSION NUMBER: 0000899243-19-015014
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190524
FILED AS OF DATE: 20190529
DATE AS OF CHANGE: 20190529
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chin Mark
CENTRAL INDEX KEY: 0001734389
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38503
FILM NUMBER: 19862273
MAIL ADDRESS:
STREET 1: 20 BERKELEY SQUARE, MAYFAIR
CITY: LONDON
STATE: X0
ZIP: W1J 6EQ
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Iterum Therapeutics plc
CENTRAL INDEX KEY: 0001659323
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BLOCK 2 FLOOR 3, HARCOURT CENTRE
STREET 2: HARCOURT STREET
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: (872) 225-6077
MAIL ADDRESS:
STREET 1: BLOCK 2 FLOOR 3, HARCOURT CENTRE
STREET 2: HARCOURT STREET
CITY: DUBLIN
STATE: L2
ZIP: 2
FORMER COMPANY:
FORMER CONFORMED NAME: Iterum Therapeutics Ltd
DATE OF NAME CHANGE: 20151124
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-24
0
0001659323
Iterum Therapeutics plc
ITRM
0001734389
Chin Mark
C/O ITERUM THERAPEUTICS PLC, BLK 2
FL. 3, HARCOURT CENTRE, HARCOURT ST.
DUBLIN
L2
2
IRELAND
1
0
0
0
Ordinary Shares
2019-05-24
4
M
0
6154
A
6154
D
Ordinary Shares
1089903
I
By Arix Bioscience Holdings Ltd.
Restricted Stock Units
2019-05-24
4
M
0
6154
0.00
D
Ordinary Shares
6154
0
D
Restricted stock units converted into ordinary shares on a one-for-one basis upon vesting of the units.
The reporting person is an Investment Director for Arix Bioscience Holdings Ltd.
On May 24, 2018, the reporting person was granted an award of 6,154 restricted stock units, which vested on May 24, 2019.
/s/ Mark Chin
2019-05-27